NYSE:OSCRInsurance
Oscar Health (OSCR) Could Be 95% Below Fair Value After Raised 2026 Guidance
Why Oscar Health Stock Is Back in Focus After Guidance Shift
Oscar Health (OSCR) is back on many investors’ watchlists after Q2 2026 earnings beat market expectations and the company raised its full year 2026 revenue and earnings guidance.
See our latest analysis for Oscar Health.
The raised guidance and stronger Q2 earnings have come after a sharp run in Oscar Health’s share price, with a year to date share price return of 84.84% and a three year total shareholder return of 298.70%. This is...